Literature DB >> 9744829

Identifying patient populations at high risk for stroke.

R L Sacco1.   

Abstract

Although the treatment of acute ischemic stroke has improved, the greatest reductions in stroke mortality and morbidity may possibly be achieved through more effective prevention strategies. Toward this goal, risk factor profiles for initial and recurrent stroke have been identified through longitudinal epidemiologic studies. Nonmodifiable risk markers for initial ischemic stroke include age, sex, family history, and race/ethnicity. Modifiable risk factors for first ischemic stroke include hypertension, cardiac disease (particularly atrial fibrillation), diabetes, hyperlipidemia, cigarette smoking, alcohol abuse, physical inactivity, asymptomatic carotid stenosis, and transient ischemic attack. As improved acute treatments increase survival after a first stroke, the threat of increased morbidity from stroke recurrence will have greater significance. The risk and specific determinants of early and late stroke recurrence are the subject of ongoing investigations. Age, stroke syndrome, hypertension, cardiac disease (particularly congestive heart failure), hyperglycemia, and alcohol abuse have been identified as predictors of late stroke recurrence. Now that many risk factors are established, greater emphasis should be placed on identifying high stroke-risk patient populations for intensive risk factor modification and antithrombotic treatments. Better understanding and management of stroke risk factors will undoubtedly improve our ability to prevent first and recurrent ischemic stroke.

Entities:  

Mesh:

Year:  1998        PMID: 9744829     DOI: 10.1212/wnl.51.3_suppl_3.s27

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

2.  Carotid duplex ultrasound and transcranial Doppler findings in commercial divers and pilots.

Authors:  Banafshe Dormanesh; Kia Vosoughi; Fahimeh H Akhoundi; Masoud Mehrpour; Seyed-Mohammad Fereshtehnejad; Setareh Esmaeili; Azin Shafiee Sabet
Journal:  Neurol Sci       Date:  2016-07-26       Impact factor: 3.307

3.  Recurrent Ischemic Stroke Characteristics and Assessment of Sufficiency of Secondary Stroke Prevention.

Authors:  Gülşen Kocaman; Hümeyra Dürüyen; Abdulkadir Koçer; Talip Asil
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

4.  Factors influencing treatment compliance among Turkish people at risk for stroke.

Authors:  Abdulkadir Koçer; Nurhan Ince; Emel Koçer; Atilla Taşçi
Journal:  J Prim Prev       Date:  2006-01-19

5.  Neural stem cell transplantation promotes behavioral recovery in a photothrombosis stroke model.

Authors:  Junning Ma; Junwei Gao; Boru Hou; Jixing Liu; Sihua Chen; Guizhong Yan; Haijun Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 6.  Androgens and stroke: good, bad or indifferent?

Authors:  Nidia Quillinan; Guiying Deng; Himmat Grewal; Paco S Herson
Journal:  Exp Neurol       Date:  2014-02-08       Impact factor: 5.330

7.  Impact of carotid atherosclerosis combined with hypercholesterolemia on cerebral microvessels and brain parenchyma in a new complex rat model.

Authors:  Lan Zhang; Bailiu Ya; Pan Yang; Fangling Sun; Li Zhang; Yali Li; Lin Li
Journal:  Neurochem Res       Date:  2014-01-29       Impact factor: 3.996

Review 8.  Statins and their use in preventing carotid disease.

Authors:  Henrik Sillesen
Journal:  Curr Atheroscler Rep       Date:  2009-07       Impact factor: 5.113

9.  Stroke Recurrence and Its Relationship With Language Abilities.

Authors:  Emily B Goldberg; Erin L Meier; Shannon M Sheppard; Bonnie L Breining; Argye E Hillis
Journal:  J Speech Lang Hear Res       Date:  2021-05-27       Impact factor: 2.297

10.  Co-Occurrence of Arthritis and Stroke amongst Middle-Aged and Older Adults in Canada.

Authors:  Roman Matveev; Chris I Ardern
Journal:  Stroke Res Treat       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.